As people will be aware, there is still a lot of uncertainty in the country and across the NHS about the impact that any future changes to our relationship with the European Union will have.

Preparations are being made by the government at a national level and by the NHS. As part of these preparations, we have also been looking at the potential impact.

Plans and contingencies are in place and we are very carefully monitoring the position.

Our workforce team is managing the situation with any employees impacted and there is currently no impact on recruitment. We have confidence in our supply chain’s ability to source medicines and national plans are in place for the provision of essential treatment components such as radioisotopes.

We will not be stockpiling medicines and neither should any patients.

Information for patients around continuity of medicine supplies if there is a no-deal EU exit can be found on the website. Details have also been supplied to clinicians around the government’s multi-layered approach to ensure that medicines continue to be available if there is a no-deal EU exit. Front line staff have been made aware of this.

Throughout this process, we have followed all the government advice provided, and as things develop week by week we will continue to review the position in light of any new information becoming available. We have a group at the Trust monitoring the situation and it is primed to put plans into place to react quickly if necessary.

October 2019 update

While an extension to the UK's membership of the EU has been agreed, we are continuing to closely monitor developments. Our position on the actions required has not changed and all of the above messaging still applies.